Evidence map›Paper›PMID 38569909›Full record

ArticleInternal medicine (Tokyo, Japan)2024

A Study of the Risk Factors for 402 Patients with Esophageal Squamous Cell Carcinoma - A Retrospective Comparison with Health Checkup Participants.

Jun Nakamura, Ken Haruma, Noriaki Manabe, Tomoki Yamatsuji, Yoshinori Fujiwara, Takahisa Murao, Minoru Fujita, Akiko Shiotani, Mitsuhiko Suehiro, Hirofumi Kawamoto and 8 more

Open access · diamondAbstract readComparative Study
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 93% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 2 institutions in 1 country.

Jun NakamuraDivision of Endoscopy and Ultrasonography, Department of Clinical Pathology and Laboratory Medicine, Kawasaki Medical School, Japan.
Ken HarumaDepartment of General Internal Medicine 2, Kawasaki Medical School, Japan.
Noriaki ManabeDivision of Endoscopy and Ultrasonography, Department of Clinical Pathology and Laboratory Medicine, Kawasaki Medical School, Japan.
Tomoki YamatsujiDepartment of General Surgery, Kawasaki Medical School, Japan.
Yoshinori FujiwaraDepartment of Digestive Surgery, Kawasaki Medical School, Japan.
Takahisa MuraoDepartment of Health Care Medicine, Kawasaki Medical School, Japan.
Minoru FujitaDivision of Endoscopy and Ultrasonography, Department of Clinical Pathology and Laboratory Medicine, Kawasaki Medical School, Japan.
Akiko ShiotaniDivision of Gastroenterology, Department of Internal Medicine, Kawasaki Medical School, Japan.
Mitsuhiko SuehiroDepartment of General Internal Medicine 2, Kawasaki Medical School, Japan.
Hirofumi KawamotoDepartment of General Internal Medicine 2, Kawasaki Medical School, Japan.
Minoru HaisaDepartment of General Surgery, Kawasaki Medical School, Japan.
Tomio UenoDepartment of Digestive Surgery, Kawasaki Medical School, Japan.
Tomoari KamadaDepartment of Health Care Medicine, Kawasaki Medical School, Japan.
Toshihiro TakaoDepartment of Health Care Medicine, Kawasaki Medical School, Japan.
Yasumasa MonobeDepartment of Pathology, Okayama Medical Laboratories Co., Ltd., Japan.
Takashi AkiyamaDepartment of Pathology, Kawasaki Medical School, Japan.
Yoshio NaomotoDepartment of General Surgery, Kawasaki Medical School, Japan.
Jiro HataDivision of Endoscopy and Ultrasonography, Department of Clinical Pathology and Laboratory Medicine, Kawasaki Medical School, Japan.
Kawasaki Medical School · JPMedical & Biological Laboratories (Japan) · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective Esophageal cancer is a gastrointestinal cancer with a poor prognosis. However, it is curable and can be treated endoscopically if it is detected at an early stage. The objective of this study was to identify the factors that contribute to early detection. Methods From April 2011 to December 2019, we retrospectively investigated consecutive patients diagnosed with esophageal squamous cell carcinoma (ESCC) through upper gastrointestinal endoscopy at two hospitals of Kawasaki Medical University based on medical records. The factors contributing to the early detection of ESCC were investigated by comparing patients with ESCC with those undergoing health checkups in whom no organic lesions were found in the upper gastrointestinal tract on endoscopy (controls). Patients Factors contributing to early detection were examined in 402 ESCC cases and 391 sex- and age-matched controls, and early and advanced cancers were compared along with the risk factors for ESCC. Results A multivariate analysis showed that alcohol consumption and smoking, concomitant cancer of other organs, and a low body mass index (BMI) were factors associated with ESCC (odds ratio [OR], 4.65; 95% confidence interval [CI], 2.880-7.520, OR, 3.63; 95% CI, 2.380-5.540, OR, 2.09; 95% CI, 1.330-3.270, OR, 6.38; 95% CI, 3.780-10.800), whereas dyslipidemia was significantly less common in patients with ESCC (OR, 0.545; 95% CI, 0.348-0.853). Comparing early and advanced cancers, a history of endoscopic screening was the only factor involved in early detection (OR, 7.93; 95% CI, 4.480-14.000). Conclusion The factors associated with ESCC include alcohol consumption, smoking, concomitant cancer of other organs, and a low BMI. Endoscopy in subjects with these factors may therefore be recommended for the early detection of ESCC.

Indexed as

Alcohol DrinkingEarly Detection of CancerEsophageal NeoplasmsEsophageal Squamous Cell CarcinomaSmokingAdultAgedBody Mass IndexFemaleHumansMaleMiddle AgedRetrospective StudiesRisk Factorsearly detectionesophageal squamous cell carcinomarisk factors

Identifiers

PMID38569909
PMCPMC11637797
OpenAlexW4393394875

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.